PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28934275-11	2017	Thus, the combination of sorafenib and MK-2206 led to significant reversion of the EMT phenotype and P-gp-mediated MDR by downregulating phosphorylated AKT.	MK 2206	39-46	ATP binding cassette subfamily B member 1	Homo sapiens	101-105	
29130495-8	2018	Matrine was more likely to reduce the expression of P-gp, MRP1, and p-AKT at the same inhibition radio of Matrine, (0.6 mg/mL) and MK2206 (0.05 mumol/L).	MK 2206	131-137	ATP binding cassette subfamily B member 1	Homo sapiens	52-56	
27486760-0	2016	Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.	MK 2206	32-38	ATP binding cassette subfamily B member 1	Homo sapiens	92-106	
27486760-6	2016	Inhibition of Akt activity using MK2206 decreased GRP78 expression in OS cells, which enhanced the inhibitory effect of MK2206 on P-gp expression.	MK 2206	33-39	ATP binding cassette subfamily B member 1	Homo sapiens	130-134	
27486760-6	2016	Inhibition of Akt activity using MK2206 decreased GRP78 expression in OS cells, which enhanced the inhibitory effect of MK2206 on P-gp expression.	MK 2206	120-126	ATP binding cassette subfamily B member 1	Homo sapiens	130-134